[Anticancer treatment and bromelains].
D000230:Adenocarcinoma / Q000188:drug therapy*; D000284:Administration, Oral; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy*; D001963:Bromelains / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004349:Drug Packaging; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008207:Lymphatic Metastasis; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008408:Mastectomy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010534:Peritoneal Neoplasms / Q000188:drug therapy*; D011379:Prognosis; D012878:Skin Neoplasms / Q000188:drug therapy*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D001963:Bromelains
Thérapeutique anti-cancereuse et bromelaïnes.